Peter Zarb

3.8k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Peter Zarb is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and General Health Professions. According to data from OpenAlex, Peter Zarb has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Applied Microbiology and Biotechnology, 10 papers in Epidemiology and 8 papers in General Health Professions. Recurrent topics in Peter Zarb's work include Antibiotic Use and Resistance (22 papers), Patient Satisfaction in Healthcare (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Peter Zarb is often cited by papers focused on Antibiotic Use and Resistance (22 papers), Patient Satisfaction in Healthcare (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Peter Zarb collaborates with scholars based in Malta, Belgium and United Kingdom. Peter Zarb's co-authors include Herman Goossens, Vanessa Vankerckhoven, Susan Hopkins, C. Suetens, Dominique L. Monnet, Arno Müller, Boudewijn Catry, K. Weist, B. Coignard and Michael Borg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

Peter Zarb

21 papers receiving 1.1k citations

Hit Papers

The European Centre for Disease Prevention and Control (E... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Zarb Malta 12 606 400 270 227 221 23 1.1k
Marion Elligsen Canada 19 653 1.1× 481 1.2× 200 0.7× 212 0.9× 251 1.1× 49 1.2k
Cees M. Verduin Netherlands 16 425 0.7× 637 1.6× 272 1.0× 201 0.9× 103 0.5× 30 1.3k
Tommi Kärki Sweden 15 346 0.6× 372 0.9× 302 1.1× 211 0.9× 254 1.1× 24 1.1k
Jacqueline Sneddon United Kingdom 21 721 1.2× 258 0.6× 178 0.7× 342 1.5× 107 0.5× 61 1.1k
Maha Talaat Egypt 23 342 0.6× 680 1.7× 311 1.2× 181 0.8× 130 0.6× 43 1.5k
Lisa Davidson United States 19 484 0.8× 389 1.0× 302 1.1× 315 1.4× 87 0.4× 48 1.7k
Mamoon A. Aldeyab United Kingdom 22 807 1.3× 472 1.2× 462 1.7× 261 1.1× 179 0.8× 83 1.5k
Ralph L. Cordell United States 12 324 0.5× 257 0.6× 287 1.1× 180 0.8× 133 0.6× 21 1.1k
Sandra A N Walker Canada 16 357 0.6× 341 0.9× 169 0.6× 147 0.6× 138 0.6× 45 863
David N. Schwartz United States 19 512 0.8× 616 1.5× 263 1.0× 246 1.1× 229 1.0× 56 1.4k

Countries citing papers authored by Peter Zarb

Since Specialization
Citations

This map shows the geographic impact of Peter Zarb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Zarb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Zarb more than expected).

Fields of papers citing papers by Peter Zarb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Zarb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Zarb. The network helps show where Peter Zarb may publish in the future.

Co-authorship network of co-authors of Peter Zarb

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Zarb. A scholar is included among the top collaborators of Peter Zarb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Zarb. Peter Zarb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarb, Peter, et al.. (2024). Prevalence of Antibiotic Prescription in Primary Healthcare Settings in the Municipality of Prishtina, Kosovo. SHILAP Revista de lepidopterología. 14(1). 134–140.
2.
Borg, Michael, et al.. (2021). Universal admission screening: a potential game-changer in hospitals with high prevalence of MRSA. Journal of Hospital Infection. 113. 77–84. 5 indexed citations
3.
4.
Scott, Michael, C. Hibberd, Ann Versporten, et al.. (2018). Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool. Epidemiology and Infection. 146(8). 985–990. 19 indexed citations
5.
6.
Saliba‐Gustafsson, Erika A., et al.. (2018). Antibiotic prescribing for respiratory tract complaints in Malta: a 1 year repeated cross-sectional surveillance study. Journal of Antimicrobial Chemotherapy. 74(4). 1116–1124. 8 indexed citations
7.
Zarb, Peter, et al.. (2017). Antimicrobial consumption in Albanian reference teaching hospital (2012-2015). The Journal of Infection in Developing Countries. 11(6). 517–520. 1 indexed citations
8.
Zarb, Peter, et al.. (2016). Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania—a point prevalence survey. Antimicrobial Resistance and Infection Control. 5(1). 29–29. 8 indexed citations
9.
Pristaš, Irina, Bruno Baršić, Iva Butić, et al.. (2013). Point prevalence survey on antibiotic use in a Croatian Infectious Disease Hospital. Journal of Chemotherapy. 25(4). 222–228. 4 indexed citations
10.
Zarb, Peter, Brice Amadéo, Nico Drapier, et al.. (2012). Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clinical Microbiology and Infection. 18(10). E389–E395. 23 indexed citations
11.
Zarb, Peter, B. Coignard, Arno Müller, et al.. (2012). The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance. 17(46). 600 indexed citations breakdown →
12.
Zarb, Peter & Herman Goossens. (2012). Human use of antimicrobial agents. Revue Scientifique et Technique de l OIE. 31(1). 121–133. 16 indexed citations
13.
Zarb, Peter & Herman Goossens. (2011). European Surveillance of Antimicrobial Consumption (ESAC). Drugs. 71(6). 745–755. 100 indexed citations
14.
Zarb, Peter, Faranak Ansari, Arno Müller, et al.. (2011). Drug Utilization 75% (DU75%) in 17 European Hospitals (2000 - 2005): Results from the ESAC-2 Hospital Care Sub Project. Current Clinical Pharmacology. 6(1). 62–70. 16 indexed citations
15.
Catry, Boudewijn, Katrien Latour, Karl Mertens, et al.. (2011). Parenteral versus Oral Administration of Systemic Antimicrobials in European Nursing Homes. Drugs & Aging. 28(10). 809–818. 6 indexed citations
16.
Zarb, Peter, Brice Amadéo, Arno Müller, et al.. (2011). Antimicrobial Prescribing in Hospitalized Adults Stratified by Age. Drugs & Aging. 29(1). 53–62. 6 indexed citations
17.
Amadéo, Brice, Peter Zarb, Nico Drapier, et al.. (2010). European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. Journal of Antimicrobial Chemotherapy. 65(10). 2247–2252. 92 indexed citations
18.
Borg, Michael, et al.. (2009). Antibiotic Resistance Surveillance and Control in the Mediterranean Region: report of the ARMed Consensus Conference. The Journal of Infection in Developing Countries. 3(9). 654–659. 13 indexed citations
19.
Borg, Michael, Peter Zarb, Elizabeth Scicluna, et al.. (2009). Antibiotic consumption as a driver for resistance in Staphylococcus aureus and Escherichia coli within a developing region. American Journal of Infection Control. 38(3). 212–216. 19 indexed citations
20.
Borg, Michael, et al.. (2008). Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. Journal of Antimicrobial Chemotherapy. 62(4). 830–836. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026